Skip to content

CT Evaluation of Cardiovascular Risk Markers in Obese Patients

CT Evaluation of Cardiovascular Risk Markers in Obese Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03111693
Acronym
RisqOScan
Enrollment
123
Registered
2017-04-13
Start date
2014-11-30
Completion date
2017-12-31
Last updated
2017-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Risks Markers, Epicardial Fat, Low Dose Computed Tomography, Metabolic Syndrome, Obesity

Keywords

Epicardial fat, Obesity, Cardiovascular risks markers, Metabolic syndrome, Low dose computed tomography

Brief summary

Obesity is a chronic metabolic disorder : it leads to coronary heart disease and early atherosclerosis. Coronary artery calcium measured by CT is known as a robust predictor to predict risk for cardiac events in symptomatic and asymptomatic individuals. Furthermore, recent studies show that other CT risk factor exists, independent of calcium scoring, such as epicardial fat, intrathoracic fat and visceral fat. The aim of this prospective study is to evaluate these new cardiovascular risk markers in obese patients, using standard dose CT and low dose CT with adaptative statistical iterative reconstruction.

Detailed description

In this prospective single-center study, obese patients of our clinical nutrition service, hospitalized for nutritional assessement, are included. All unenhanced coroCT examinations are performed on the same 64-Row CT scanner (discovery CT 750 HD scanner, GE Healthcare), using prospective ECG-triggerring. The investigation protocol began with a standard-dose acquisition followed immediately by a low-dose acquisition, recorded over strictly identical segments (identical first and last sections). After these two examinations, estimated dose values are less than the diagnostic scan reference level for a coroCT.

Interventions

OTHERUnenhanced Coro-CT

All unenhanced coroCT examinations are performed on the same 64-Row CT scanner (discovery CT 750 HD scanner, GE Helthcare), using prospective ECG-triggerring.

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* obesity \>30 indicated non enhanced coroCT for calcium scoring.

Exclusion criteria

* \<18 ans * low Framingham scoring * pregnancy * not providing informed consent * history of cardiovascular disease.

Design outcomes

Primary

MeasureTime frame
Epicardial fat evaluation in obese populationat day 1

Secondary

MeasureTime frame
Calcium scoring evaluationat day 1

Countries

France

Contacts

Primary ContactPatrick LACARIN
placarin@chu-clermontferrand.fr04 73 75 11 95

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026